The activity of IFN-γ-inducible CXC chemokines mediated via CXCR3 was firstly investigated using a model of DENV-induced neurological disease in wild-type (WT), CXCR3-or CXCL10/IP-10 deficient mice [61]. Here, CXCL10 is linked to nervous system disorder.